Introduction
The Rel/NF-kB family of transcription factors have important roles in immune and inflammatory responses, proliferation and apoptosis (Aggarwal, 2004; Bonizzi and Karin, 2004) . Vertebrate members of this evolutionarily conserved family include NF-kB1 (p50), NF-kB2 (p52), RelA (p65), RelB and c-Rel. In unstimulated cells, Rel/NF-kB proteins are retained in the cytoplasm through association with IkB proteins. Activation of IkB kinases (IKKs) results in the degradation of IkB proteins, allowing the nuclear translocation of Rel/NF-kB complexes which then regulate the expression of a wide range of target genes through binding to specific decameric DNA sites (kB sites) (Chen and Ghosh, 1999) .
Elevated expression of Rel/NF-kB proteins and/or disruption in IKK/IkB regulation has been linked to several types of cancer (Rayet and Gelinas, 1999; Courtois and Gilmore, 2006) . The earliest evidence of a role for Rel/NF-kB proteins in oncogenic cell transformation resulted from studies with v-rel. The v-rel oncogene is derived from the transduction of c-rel into an avian retrovirus (Stephens et al., 1983) . Although c-Rel is only weakly oncogenic, v-Rel is the most efficient transforming member of the Rel/NF-kB family. It induces avian and mammalian lymphoid cell tumors and, in vitro, can efficiently transform cells of hematopoietic origin and chicken embryonic fibroblasts (Liss and Bose, 2008) . v-Rel derives its strong oncogenicity from alterations in DNA binding specificity and transactivation potential as well as its ability to escape inhibition by IkB proteins (Gilmore, 1999) . Transformation by v-Rel is mediated by the aberrant expression of genes that are normally tightly regulated by Rel/NF-kB proteins.
Our previous studies demonstrated that v-Rel selectively alters the expression of several AP-1 family members and that general inhibition of AP-1 activity dramatically reduced the ability of v-Rel to transform both fibroblasts and lymphoid cells (Kralova et al., 1998) . AP-1 proteins are a family of transcription factors that regulate cell proliferation, differentiation and apoptosis in response to external stimuli (Hess et al., 2004) . The AP-1 family is composed of Jun, Fos and ATF proteins, all of which contain a common basicregion leucine zipper important for dimerization and DNA binding. Jun family members (c-Jun, JunB and JunD) have the ability to form stable homodimers as well as heterodimers with Fos and ATF family members. Similarly, members of the ATF family (ATF2, ATF3 and ATF4) can homodimerize and selectively heterodimerize with Jun proteins. Members of the Fos family (c-Fos, FosB, Fra-1 and Fra-2), however, can only form heterodimers. Jun homodimers and Jun-Fos dimers preferentially bind to the TPA-responsive element (TRE; 5 0 -TGA(C/G)TCA-3 0 ), whereas Jun-ATF dimers and ATF homodimers display a strong affinity for DNA sites containing cAMP-responsive elements (CRE; 5 0 -TGACGTCA-3 0 ) (Angel et al., 1987 (Angel et al., , 1988 Hai and Curran, 1991) . In addition to changes in gene expression, AP-1 activity is regulated by posttranslational modifications, including phosphorylation by mitogen-activated protein kinases (MAPKs) (Karin et al., 1997) . Phosphorylation of pre-existing and newly synthesized AP-1 components by the JNK, ERK or p38 MAPK cascades activates and stabilizes the dimeric AP-1 complexes, thereby enhancing their transactivation potential.
In this report, the role of individual AP-1 proteins in the v-Rel transformation process was evaluated. Our results show that c-Fos and c-Jun are key players in v-Rel-mediated transformation, and the inability of c-Rel to induce their expression contributes to its weaker oncogenic potential. Although elevated expression of ATF2 appears to be required for v-Rel-mediated transformation, its ectopic overexpression is inhibitory. Characterization of the negative effect of ATF2 on transformation by v-Rel revealed a novel role for ATF2 in the regulation of the Ras-Raf-MEK-ERK signaling pathway.
Results

Altered expression of AP-1 family members in v-Rel-transformed cells
For a detailed analysis of the role of individual AP-1 proteins in v-Rel-mediated transformation, we assessed the ability of c-Rel and v-Rel to alter the expression of c-fos, c-jun, fra-2 and ATF2 at both the RNA and protein levels. c-Jun, c-Fos and ATF2 expression was upregulated in v-Rel-transformed chicken embryonic fibroblasts (CEFs) and lymphoid cells (DT40 and DT95) and, to a moderate extent, in cells transformed by c-Rel (Supplementary Figures 1a and b) . Fra-2 expression remained unchanged in cells ectopically expressing c-Rel; however, it was downregulated at both the RNA and protein level in v-Rel-transformed CEFs and DT40 cells.
v-Rel directly activates the human c-jun promoter, and the presence of similar kB sites in the promoter of the avian homolog suggests that it is a direct target of v-Rel (Fujii et al., 1997) . Employing a combination of luciferase reporter assays, electrophoretic mobility shift assays (EMSAs) and chromatin immunoprecipitation experiments, we demonstrated that the induction of c-fos by v-Rel is also likely because of direct promoter activation (Supplementary Figures 2a-d) . ATF2 is also a candidate v-Rel target gene as there are two kB sites in its proximal promoter that can be bound by v-Rel-containing complexes (Supplementary Figure 2e) . In addition to elevating the expression of AP-1 proteins, v-Rel efficiently induced the activity of luciferase reporter constructs specific for both Fos/Jun and ATF/Jun dimers (Supplementary Figure 1c) , indicating that, in contrast to c-Rel, the expression of v-Rel is sufficient to activate the expression and activity of these distinct AP-1 pathways.
AP-1 proteins exhibit altered DNA-binding profiles in v-Rel-transformed cells To directly assess contributions of individual AP-1 family members in v-Rel-mediated transformation, bicistronic retroviral vectors were constructed to express c-fos, c-jun, fra-2 and ATF2 alone or in combination with v-rel. DT40 cells infected with viruses expressing v-Rel alone induced the expression of c-Fos, c-Jun and ATF2 while suppressing the expression of Fra-2 (Figures 1a-d ). In addition, the co-expression of v-Rel with c-fos, c-jun, fra-2 and ATF2 resulted in higher levels of these AP-1 gene products than observed in cells expressing control viruses or viruses expressing v-Rel alone.
To determine whether these elevated AP-1 protein levels resulted in a corresponding change in AP-1 DNA-binding activity, EMSAs were performed with nuclear extracts from DT40 cells infected with these viruses. The overexpression of v-Rel alone resulted in a strong induction of two AP-1 complexes that bound to a site specific for Fos/Jun dimers ( Figure 1e , bands 1 and 2). Supershift analysis indicated that these complexes were composed of c-Fos, c-Jun and Fra-2 (Figures 1g-i) . Overexpression of c-Fos or Fra-2 alone resulted in enhanced DNA-binding activity over that of control BIS-infected cells. Furthermore, nuclear extracts from cells that co-expressed v-Rel with c-Fos or Fra-2 exhibited increased binding activity of the slower migrating complex (band 2) and reduced binding of the faster migrating complex (band 1). Overexpression of c-Jun alone did not alter AP-1 DNA-binding activity; however, co-expression of v-Rel with c-Jun resulted in an increase in both DNA-binding complexes observed in cells expressing v-Rel alone. An additional slower migrating form was also observed in these cells (band 3). Supershift analysis showed the altered DNA-binding profiles observed in extracts from cells ectopically expressing AP-1 proteins were due to the presence of the overexpressed protein (Figures 1g-i) . Overexpression of ATF2 alone or with v-Rel did not alter AP-1 DNA-binding activity on this site.
In addition to altering DNA-binding activity on a Fos/Jun-specific binding site, v-Rel induced DNA binding on a site specific for ATF2/Jun dimers ( Figure 1f , bands 3 and 5). Supershift analysis revealed the presence of c-Jun and ATF2 in these complexes (Figures 1j and k) . Overexpression of ATF2 alone or with v-Rel resulted in an increase in DNA-binding activity. In addition, the co-expression of c-Jun with v-Rel strongly induced the slowest migrating complex (band 5). Supershift analysis showed that the altered DNA-binding profile observed above was due to the presence of overexpressed c-Jun or ATF2 (Figures 1j  and k) . As expected, the overexpression of c-Fos or Fra-2 did not alter binding on this site. Taken together, these results demonstrate that induction of c-Fos, c-Jun and ATF2 by v-Rel correlates with their enhanced DNAbinding activity and that the bicistronic retroviral vectors can effectively elevate the levels and DNAbinding activity of c-Fos, c-Jun, Fra-2 and ATF2 to a greater extent than cells expressing v-Rel alone. Supershift analyses were performed with the extracts described above employing normal rabbit serum (NRS) or antisera specific to c-Fos, c-Jun, Fra-2 and ATF2. Probes containing AP-1 DNA-binding sites specific for Fos/Jun (g-i) or ATF2/Jun heterodimers (j-k) were employed for these studies. The asterisk to the right of each panel indicates the location of the supershifted band(s).
Distinct role of AP-1 factors in Rel/NF-jB oncogenesis AS Liss et al Elevated expression of c-Fos and c-Jun enhances transformation of Rel proteins To determine whether alterations in the activity of c-Fos, c-Jun, Fra-2 and ATF2 can alter the transformation potential of v-Rel, primary splenic lymphocytes were infected with the bicistronic viruses described above. Overexpression of individual AP-1 proteins from these viruses failed to transform cells (Table 1) . However, consistent with their induction by v-Rel, the coexpression of c-Fos or c-Jun with v-Rel resulted in a three-to four-fold enhancement in colony formation relative to viruses expressing v-Rel alone. Overexpression of Fra-2 resulted in a modest increase in colony formation, suggesting that the downregulation of Fra-2 by v-Rel is not an important event during transformation and therefore, the involvement of Fra-2 in v-Relmediated transformation was not investigated further. Unexpectedly, viruses co-expressing ATF2 and v-Rel were less effective at transforming splenic lymphocytes than viruses expressing v-Rel alone.
To gain additional insight into the contribution of elevated levels of c-Fos, c-Jun and ATF2 to v-Relmediated transformation, retroviral vectors were constructed to express shRNAs that targeted c-fos, c-jun and ATF2. The ability of a specific shRNA to effectively reduce the levels of its targeted endogenous AP-1 family member was evaluated in 160/2 cells, a v-Rel-transformed cell line. Cells were infected with empty viruses (RCAS), viruses encoding shRNAs specific for each AP-1 family member, or a shRNA specific for luciferase (luc) as a negative control. The expression of c-Fos, c-Jun and ATF2 was reduced by 30-60% in cells expressing the specific shRNAs relative to cells infected with the empty virus or virus encoding a shRNA specific for luciferase (Figures 2a-c) .
The shRNA-encoding retroviruses were then evaluated for their ability to alter the transformed phenotype of 160/2 cells. Viruses encoding shRNAs specific for c-Fos, c-Jun and ATF2 reduced the ability of these cells to form colonies in soft agar by approximately 60% relative to cells infected with empty control virus (Figure 2e ). In contrast, cells infected with viruses encoding a shRNA specific for luciferase had no effect on colony formation. These results demonstrate a direct correlation between the levels of c-Fos, c-Jun and ATF2 with the ability of v-Rel-transformed cells to form colonies in soft agar.
Alterations in the expression of c-Fos and c-Jun affecting the transformed phenotype suggested a role for these proteins in v-Rel-mediated transformation (Table 1  and The observation that overexpression of ATF2 reduced the transformation potential of v-Rel in splenic lymphocytes (Table 1) Splenic lymphocytes were infected with indicated retroviruses, plated in soft agar, and colonies were scored microscopically after 10 days. The number of colonies (ranging from 53 to 731) from BIS-V infections were normalized to 100 for each experiment. No colonies were observed with control BIS viruses or BIS viruses expressing AP-1 family members alone.
Distinct role of AP-1 factors in Rel/NF-jB oncogenesis AS Liss et al reduced oncogenic potential of c-Rel relative to v-Rel is due, at least in part, to its inability to elevate expression of c-Jun and c-Fos.
Overexpression of ATF2 inhibits v-Rel-induced activation of Ha-Ras
The experiments presented above indicated an ambiguous role of ATF2 in v-Rel-mediated transformation. v-Rel induces the expression of ATF2 and when this expression is reduced, it results in an attenuated oncogenic phenotype. However, further elevation of ATF2 levels inhibits transformation by Rel proteins.
As the transcriptional activity of ATF2 is largely regulated by the phosphorylation of Thr69 and Thr71, we evaluated whether the phosphorylation status of these sites may contribute to the inhibition of transformation by v-Rel. Levels of total and phosphorylated ATF2 were measured by western blot analysis using lysates from CEFs and DT40 cells expressing control BIS viruses, BIS expressing v-Rel or ATF2 alone, or co-expressing v-Rel and ATF2 (Figure 5a ). In both cell types, the expression of v-Rel resulted in slightly elevated levels of phosphorylated ATF2 relative to control cells. Cells that overexpressed ATF2 alone or coexpressed ATF2 and v-Rel exhibited higher levels of phosphorylated ATF2 than cells expressing v-Rel alone. These results suggest that the expression of ATF2 is able to activate the pathway(s) that lead to its own phosphorylation.
As the JNK, p38 and ERK MAPK pathways have all been implicated in the phosphorylation of ATF2 under various conditions, we investigated whether the activity of one or more of these pathways was altered by the expression of ATF2 (Morton et al., 2004) . Whole cell lysates from CEFs and DT40 cells expressing control BIS virus or BIS viruses expressing ATF2 were analyzed by western blot to determine the activation state of various members of the MAPK pathways (Figure 5b) . In CEFs and DT40 cells overexpressing ATF2, an increase in the levels of active, phosphorylated p38 was observed. A slight activation of JNK was observed in DT40 cells overexpressing ATF2, but this activity was not altered in CEFs. The levels of active ERK were reduced in both CEFs and DT40 cells overexpressing ATF2.
Chemical inhibitors specific to each MAPK pathway were employed to further determine which pathway was responsible for phosphorylation of ATF2. DT40 cells infected with control BIS viruses or BIS viruses expressing ATF2 were treated with inhibitors specific to the p38, JNK or ERK pathways and whole cell lysates were prepared. Western blot analysis demonstrated that inhibition of p38, but not JNK or ERK, reduced the levels of phosphorylated ATF2 in cells overexpressing ATF2 (Figure 5c ). The experiments described above suggest that overexpression of ATF2 results in the activation of p38, which leads to enhanced phosphorylation of ATF2. The RCAS-infected 160/2 cells described above were also plated in soft agar and scored for colony formation after 8 days. The number of colonies from each experiment was normalized to control RCAS-infected cells. The average and s.d. of three independent experiments is shown. (f) The BIS viruses described above were used to infect splenic lymphocytes from 3-week-old chickens. Infected cells were plated in soft agar 3 days later and colonies scored after 10 days. The average and s.d. of four independent experiments is shown.
Distinct role of AP-1 factors in Rel/NF-jB oncogenesis AS Liss et al Our observation that the levels of phosphorylated, active ERK are decreased upon overexpression of ATF2 was especially interesting since ERK is one of the downstream effectors of Ha-Ras (Robbins et al., 1992) . Therefore, we investigated whether v-Rel activates the ERK pathway and if the overexpression of ATF2 disrupts this process. The levels of total and active forms of the upstream components of the ERK pathway were determined by western blot analysis using whole cell lysates from CEFs and DT40 cells infected with control BIS viruses or BIS viruses expressing v-Rel or ATF2, alone or in combination. The expression of v-Rel in fibroblasts and lymphoid cells resulted in high levels of phosphorylated c-Raf (Ser338), MEK1/2 and ERK (components of the Ras pathway) (Figure 6a ). No increase in the total levels of these proteins was observed. Consistent with the ability of ATF2 to reduce levels of active, phosphorylated ERK, the co-expression of ATF2 with v-Rel inhibited v-Rel-mediated activation of c-Raf, MEK1/2 and ERK in fibroblasts and lymphoid cells.
Phosphorylation of c-Raf at Ser338 is dependent on the activation of Ras (Chaudhary et al., 2000; Sun et al., 2000) . To directly measure the activity of Ha-Ras, pulldown experiments were performed. Cell lysates from DT40 cells infected with viruses described above were incubated with GST-fusion proteins containing the Rasbinding domain of c-Raf, and bound proteins were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. As only active, GTP-bound Ras can bind to the substrate, the level of bound Ha-Ras is reflective of its activation state. Western blot analysis demonstrated that in cells expressing v-Rel, there are higher levels of active, GTP-bound Ras than in control cells (Figure 6b) . Furthermore, the co-expression of v-Rel with ATF2 reduced the levels of activated Ha-Ras to levels similar to those observed in control cells. In addition to evaluating the levels of active, GTP-bound Ras, we determined the levels of total Ha-Ras protein in these cells regardless of its activation state. Interestingly, v-Rel also increased the levels of total Ha-Ras in these cells, whereas the overexpresson of ATF2 had no effect.
Although ATF2 inhibited v-Rel-induced activation of the Ras-Raf-MEK-ERK pathway, the overexpression of ATF2 alone in DT40 cells resulted in the slight activation of Ha-Ras (Figure 6b ). This activation of HaRas corresponded to the elevated levels of c-Raf phosphorylated on Ser338 in DT40 cells (Figure 6a ). Despite the activation of Ha-Ras and c-Raf in DT40 cells overexpressing ATF2, reduced levels of active, phosphorylated MEK1/2 and ERK were observed. To understand this apparent contradiction, we evaluated the state of additional phosphorylation sites on c-Raf (Figure 6c ). This analysis revealed that the overexpression of ATF2 also induces the phosphorylation of c-Raf at Ser259 in DT40 cells. This enhanced phosphorylation of c-Raf was not observed in fibroblast cultures. The phosphorylation of c-Raf at Ser259 has been shown to participate in the binding of 14-3-3 to inhibit c-Raf activity (Chong et al., 2001) .
In complementary experiments, the effect of reducing endogenous levels of ATF2 on the activation of the Ras pathway was analyzed (Figure 6d ). v-Rel-expressing and control DT40 cells were infected with control viruses or (Figure 6e ). To define the contribution of Ha-Ras to transformation by v-Rel, the v-Rel-transformed cell line 160/2 was infected with control virus or viruses expressing wild-type Ha-Ras or DN-Ras. The levels of active, phosphorylated ERK were evaluated in lysates from these cells (Figure 6f) . Reflective of the role HaRas has in ERK activation, cells infected with viruses expressing wild-type Ha-Ras expressed higher levels of phosphorylated ERK, whereas cells expressing DN-Ras exhibited reduced levels of active ERK. In addition to their effect on the activity of the ERK pathway, the expression of DN-Ras resulted in a 50% decrease in colony formation, whereas cells overexpressing Ha-Ras formed colonies twice as efficiently as control cells (Figure 6g ). Overall, these results reveal Ha-Ras as an effector of v-Rel transformation and show an inhibitory function of ATF2 in the Ras-signaling pathway. These results might also be extended to understanding transformation of human lymphoid cells by Rel/NF-kB. Gene amplifications of c-Rel and constitutive, nuclear Rel/NF-kB activity are among the hallmarks of certain human lymphoid malignancies, such as Hodgkin's lymphoma, diffuse large B-cell lymphoma and anaplastic large-cell lymphomas (Kalaitzidis et al., 2002; Mathas et al., 2005; Chin et al., 2009) . Interestingly, overexpression of AP-1 proteins has been linked to some of these human cancers caused by deregulated Rel/NFkB signaling (Mathas et al., 2002; Rassidakis et al., 2005; Shaulian, 2010) . By supporting proliferation, inhibiting apoptosis and synergizing with Rel/NF-kB to activate gene expression for a pro-tumorigenic response, AP-1 proteins are suggested to have an important role in lymphomagenesis. However, the mechanism by which these lymphomas give rise to aberrant AP-1 expression is not clear. Mammalian Rel/NF-kB factors are involved in positively modulating AP-1 expression. For instance, decreased expression of c-fos was observed in IKK1 À/À and IKK2 À/À MEFs, or when DNA-binding activity of RelA/NF-kB1 heterodimers was inhibited in pancreatic cells (Fujioka et al., 2004) . Our studies with v-Rel suggest that deregulated Rel/NF-kB activity can induce AP-1 activation via direct upregulation of gene expression and activation of pathways that stimulate AP-1 activity ( Supplementary  Figures 1 and 2) .
The contribution of ATF2 to oncogenesis is poorly defined. Overexpression of ATF2 alone does not transform cells; however, several lines of evidence suggest a role for ATF2 in promoting oncogenesis. ATF2 has been found to enhance proliferation in both human and mouse cancer cell lines and is implicated in prostate and breast cancers (Zoumpourlis et al., 2000; Lewis et al., 2005; Ricote et al., 2006; Vlahopoulos et al., 2008) . Conversely, other studies have revealed that mice with reduced ATF2 expression are predisposed to mammary tumors and the development of papillomas (Maekawa et al., 2007; Bhoumik et al., 2008) . Our characterization of ATF2 in v-Rel-mediated transformation similarly suggests opposing roles for ATF2 in oncogenesis. The modest increase in ATF2 expression observed in v-Reltransformed cells promotes oncogenesis, as demonstrated by reduced colony formation of cells expressing shRNAs against ATF2. However, enhanced expression of ATF2 inhibits transformation by v-Rel. These results suggest that there is a delicate balance between the oncogenic and tumor suppressor functions of ATF2.
While dissecting the dual role of ATF2 in the context of v-Rel transformation, we observed elevated levels of phosphorylated ATF2 at Thr69 and Thr71 in cells overexpressing ATF2, which was solely dependent on the activity of p38 MAPK ( Figure 5 ). In addition, overexpression of ATF2 resulted in increased p38 activity in both fibroblast and lymphoid cells. These results suggest a positive feedback mechanism whereby ATF2 induces p38 activity to further induce its own activity. Although negative feedback regulation of p38 has been reported, this is the first report of a downstream effector of p38 positively regulating its activity (Breitwieser et al., 2007) . Interestingly, deletion of the transcriptional activation domain of ATF2 in an ATF7-null background results in the activation of p38 through the downregulation of dual specificity phosphatases (DUSP) (Breitwieser et al., 2007) . Whether p38 activation induced by overexpression of ATF2 also occurs through altered expression of DUSP family members remains to be determined.
While ATF2 is able to activate p38, our novel observations of the effect of ATF2 on the ERK pathway provided insight into its transformation-inhibiting potential. We observed decreased levels of active, phosphorylated ERK in cells overexpressing ATF2 ( Figure 5) . Activation of the ERK pathway has a welldefined role in oncogenesis, and our results support a model, in which ATF2 inhibits transformation by blocking v-Rel-mediated activation of the Ras-Raf-MEK-ERK pathway (Figure 7) . v-Rel induced the activation of Ha-Ras and its downstream effector pathway components c-Raf, MEK1/2 and ERK (Figures 6 and 7a) . However, the expression of ATF2 in the presence of v-Rel blocked the activation of this pathway (Figure 7b ). Reducing ATF2 expression by shRNAs had the opposite effect, derepressing the activity of c-Raf, MEK1/2 and ERK, which further corroborated the inhibitory effects of ATF2 on this pathway (Figure 6 Our results also suggest that ATF2 can regulate signaling pathways in a cell type-specific and/or contextdependent manner. Differences were found in the stage at which ATF2 regulated the Ras/ERK signaling pathway in fibroblast and lymphoid cells. In fibroblasts, the overexpression of ATF2 (in the absence or presence of v-Rel) blocked the activation of c-Raf, MEK1/2 and ERK. However, in the DT40 B-cell line, overexpression of ATF2 in the absence of v-Rel increased Ha-Ras activity and phosphorylated c-Raf (Ser338) levels, whereas phospho-MEK1/2 and phospho-ERK levels were found to be decreased. Our results suggest that negative regulation of c-Raf activity is responsible for the reduced levels of phosphorylated MEK1/2 and ERK. Although phosphorylation of c-Raf at Ser338 is involved in positive regulation, its phosphorylation at Ser259 is known to be inhibitory, preventing the activation of downstream effectors (Chong et al., 2001) . Examination of the phosphorylation status of c-Raf revealed higher levels of phosphorylation at Ser259 in DT40 cells overexpressing ATF2 alone relative to control cells, suggesting that ATF2 can inhibit c-Raf activity through recruitment of 14-3-3 proteins (Figures 6c and 7c ). This event may be cell type-specific, because the analysis in fibroblasts did not reveal any differences in the phosphorylation status of c-Raf at Ser259 in cells overexpressing ATF2 alone. As DT40 cells are transformed by the insertional activation of c-myc by avian leukosis virus, the differential effects of ATF2 on the Ras-Raf-MEK-ERK pathway in this cell type may be due to the activity of c-Myc (Ewert and Duhadaway, 1999) . Taken together, our results suggest a model in which the overexpression of ATF2 inhibits v-Rel-mediated activation of the Ras-Raf-MEK-ERK pathway, and depending on the cellular context, may do so at different stages of the pathway.
Our studies demonstrate a clear role for c-Jun and c-Fos in the v-Rel transformation process. These are the only examples of genes differentially activated by v-Rel and c-Rel that have been shown to enhance transformation by c-Rel. However, experiments with ATF2 revealed that different AP-1 proteins can have distinct and often complex roles in transformation. Our results indicate that ATF2 can regulate the Ras-Raf-MEK-ERK pathway at multiple steps. The work of others suggests that Ras pathway inhibition by ATF2 is likely not restricted to the avian system. ATF2-null keratinocytes are more susceptible to transformation by oncogenic Ras than wild-type cells (Bhoumik et al., 2008) . Further examination of the mechanism(s) of ATF2 regulation of Ras activity will likely provide greater insight into the role of ATF2 in oncogenesis. Distinct role of AP-1 factors in Rel/NF-jB oncogenesis AS Liss et al
Materials and methods
Cell culture Primary CEFs were prepared from 10-to 11-day-old embryos (Charles River SPAFAS, Wilmington, MA, USA) and grown in Dulbecco's modified Eagle's Medium (DMEM) supplemented with 5% newborn calf serum (Atlanta Biologicals, Lawrenceville, GA, USA), 5% chicken serum and 1% Antibiotic-Antimycotic (Invitrogen Corporation, Carlsbad, CA, USA). Cells were grown at 37 1C and 8% CO 2 . The DT40 and DT95 B-cell lines, transformed by the avian leukosis virus, and the v-Rel transformed 160/2 cell lines were grown in the same conditions. Retroviral stocks were prepared using DMEM supplemented with 5% fetal calf serum instead of 5% newborn calf serum.
Retroviral vectors
Four retroviral vector systems were employed in these studies. The REV-based retroviral vectors pREV-C and pREV-TW contain the coding regions of c-Rel and v-Rel, respectively (Nehyba et al., 1997) . The bicistronic spleen necrosis virusbased pBIS retroviral vector has been previously described (Majid et al., 2006) . The ORFs encoding c-Rel and v-Rel were cloned into pBIS to form the pBIS-C and pBIS-V vector, respectively. c-jun, c-fos and ATF2 were cloned into the pBIS, pBIS-C and pBIS-V retroviral vectors and M o , fra-2 and antisense ATF2 into the pBIS and pBIS-V retroviral vectors. To generate the M 0 (E264K) mutant of avian c-Jun, a point mutation was introduced into c-Jun using the Quik-Change Site-Directed Mutagenesis Kit (Stratagene, LaJolla, CA, USA). The primer designed was as follows: 5 0 -GGAAAGG ATTGCCAGGTTGaAAGAAAAAGTGAAAAC-3 0 . Lower case letter indicates position of the mutagenic nucleotide. The mutagenized sequence of M 0 was confirmed at the DNA Sequencing Facility at the University of Texas at Austin.
The Rous sarcoma virus (RSV)-based shRNA vector system is composed of pRFPRNAiC and RCASARNAi (Das et al., 2006) . Gene-specific oligonucleotides were first cloned into pRFPRNAiC. A NotI-ClaI restriction fragment containing this cassette downstream of the chicken U6 promoter was excised and cloned into RCASARNAi to generate a retroviral vector expressing each shRNA. The oligos encoding the shRNA hairpins for each gene are described in Supplementary Materials and methods.
The RSV-based retroviral vector system, DS, which is composed of the pTZDS-XB and pREP-A plasmids, was employed to express wild-type Ha-Ras and a dominantnegative Ha-Ras mutant (Howe and Marshall, 1993; Hrdlickova et al., 2001) . The chicken Ha-Ras gene was mutated to encode a dominant-negative Ha-Ras protein (S17N) using the Quik-Change Site Directed Mutagenesis Kit (Stratagene).
Western blot analysis
Proteins from whole cell lysates were resolved by 10 or 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrophoretically transferred to Optitran nitrocellulose membranes (Schleicher and Schuell, Keene NH). For the detection of v-Rel and c-Rel, the HY87 monoclonal antibody was used (Hrdlickova et al., 1994) . Primary antibodies purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) were used to detect avian c-Fos (sc-253), c-Jun (sc-45), Fra2 (sc-604) and ATF2 (sc-6233 In vitro transformation assays In vitro transformation assays were performed as previously described (Liss and Bose, 2002) . Briefly, primary splenic lymphocytes were isolated from spleens of 3-week-old chickens, purified by differential gradient centrifugation and infected with BIS retroviruses. Cells were resuspended in DMEM media containing 15% fetal bovine serum, 5% chicken serum and 1% Antibiotic-Antimycotic 24 h after infection and incubated for an additional 2 days before plating in soft agar. For liquid transformation assays, splenic lymphocytes were infected and, a day later, resuspended in fresh DMEM as described above. After an additional 3 days, cells from each infection underwent eight 1:2 serial dilutions. 160 ml of each dilution was aliquoted into 12 wells in a 96-well plate. For both in vitro and liquid transformation assays, plates were kept at 37 1C and 8% CO 2 and colonies scored 10 days later. Liquid transformation efficiency was calculated by multiplying the number of wells showing visible growth for a specific dilution by the reciprocal of that dilution.
Soft agar colony assays of v-Rel-transformed cell lines Plating of v-Rel-transformed cells in soft agar has been previously described (Majid et al., 2006) . The 160/2 v-Reltransformed cell line was infected with empty RCAS vector or one encoding shRNAs specific for luciferase, c-Jun, c-Fos or ATF2 at an MOI of 7-10. Viable cells were counted 10 days post-infection and plated in 0.35% soft agar (DMEM containing 0.35% Noble Agar (Becton, Dickinson and Company, Sparks, MD, USA), 5% FCS, 5% CS and 1% Antibiotic-Antimycotic). Cells were plated at a concentration of 1.5 Â 10 4 cells/plate. Plates were kept at 37 1C and 8% CO 2 , and colonies were scored 7-10 days post-plating.
Electrophoretic mobility shift assays Nuclear extracts from DT40 cells were prepared as previously described (Dyer and Herzog, 1995) . In vitro translations were performed using the T7 polymerase-based TNT Coupled Reticulocyte Lysate System (Promega, Madison, WI, USA) according to the manufacturer's directions. Genes encoding c-Fos, c-Jun, M 0 and ATF2 were expressed from the pBluescript expression vector. Parallel reactions expressing these proteins alone or in combination were performed in the presence or absence of [
35 S]-methionine. Proteins containing [ 35 S]-methionine were resolved by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and quantitated by phosphorimager analysis and normalized to the number of methionines. The amounts of DNA were adjusted so that translated c-Fos and ATF2 were in two-fold excess relative to For electrophoretic mobility shift assays, 5 mg of nuclear extract or 2 ml of in vitro translated protein was incubated for 15 min at room temperature in a total reaction volume of 25 ml containing 20 mM Tris pH 7.5, 75 mM KCl, 40 mM EDTA, 5% glycerol, 1 mM dithiothreitol, 100 mg BSA/ml and 1 mg of poly[dI/dC]. [
32 P]dCTP-labeled Coll or Jun2 DNA probes (50 000 c.p.m.) were then added to the reaction mixture, which was incubated for an additional 20 min at room temperature. For supershift analysis, 4 mg of the appropriate antibody or normal rabbit serum was added and incubated on ice for 45 min before the addition of radiolabeled oligonucleotide. Antibodies for supershifts were obtained from Santa Cruz Biotechnology and are listed as follows: c-Jun (sc-45X), c-Fos (sc-253X), Fra2 (sc-604X) and ATF2 (sc-6233X). Samples were analyzed by electrophoresis on a 5% nondenaturing polyacrylamide gel in 0.25X TBE buffer. Gels were dried and DNA-protein complexes visualized by autoradiography.
The top strands of the oligonucleotide sequence used for probes are listed as follows: Coll: 5 0 -AGCTAGCAtgagtcaGA CAC-3; Jun2: 5 0 -AGCTAGCAttacctcatCCC-3 0 . The lower case letters represent nucleotides specific for Jun/Fos binding (Coll) and Jun/ATF2 binding (Jun2). The bottom strands of the probe were synthesized by annealing a 9-bp oligonucleotide complementary to the 3 0 end of the top strand and extending with Klenow in the presence of [ 32 P]dCTP (Liss and Bose, 2002) .
